IFNG and neoplasm: A study found that immune checkpoint inhibitors activate and induce CD8+ T cells to secrete interferon‐gamma (IFN‐γ), which negatively regulates the expression of the Xc system components SLC3A2 and SLC7A11 on the surface of tumor cells.